Literature DB >> 9795108

Priming enhances endotoxin-induced thermal hyperalgesia and mechanical allodynia in rats.

C M Cahill1, A Dray, T J Coderre.   

Abstract

Central inflammation is an integral component and contributor of the pathology of many debilitating diseases and has been shown to produce spontaneous pain and hyperalgesia. Recently, administration of lipopolysaccharide (LPS) into the lateral ventricle of rats was shown to elicit both thermal hyperalgesia and tactile allodynia [K. Walker, A. Dray, M. Perkins, Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 receptor antagonist treatment, Pain 65 (1996) 211-219]. In this study, we have replicated the LPS model with some adaptations and correlated the nociceptive behaviors with an increased expression of activated macrophages in the central nervous system. We also examined the effects of priming on LPS-induced decreases in thermal nociceptive thresholds and mechanical response thresholds following either central or peripheral administration. Intracerebroventricular (i.c.v.) administration of LPS (0.2 microgram/rat) did not alter either thermal (hot plate) or mechanical (von Frey filaments) thresholds compared to baseline values in the first few hours after injection. However, priming rats by pretreating with i.c.v. LPS (0.2 microgram) 24 h prior to testing with i.c.v. LPS (0.2 microgram) produced significant mechanical allodynia and thermal hyperalgesia. The mechanical allodynia had an onset of 80 min after injection and a duration of 5 h. A similar time course was observed for thermal hyperalgesia, although its expression was less pronounced. Immunohistochemical studies indicated an increased expression of activated macrophages in the brain parenchyma of primed rats but not in unprimed rats. Intraperitoneal (i.p., 2 mg/kg) administration of LPS had no significant effect on either thermal or mechanical thresholds in the first few hours after injection; however, priming rats via i.p. (0.2 mg/kg) or i.c.v. (0.2 microgram) LPS produced a reduction in both thermal nociceptive thresholds and mechanical response thresholds in rats given a subsequent i.p. injection of LPS. This study demonstrates that priming is an effective protocol for the induction of central inflammation and increases the duration of these behaviors after i.c. v. administration. Copyright 1998 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795108     DOI: 10.1016/s0006-8993(98)00786-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.

Authors:  Terence J Coderre; André Laferrière
Journal:  J Neural Transm (Vienna)       Date:  2019-11-18       Impact factor: 3.575

2.  Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model.

Authors:  Sefika Pinar Senol; Meryem Temiz-Resitoglu; Demet Sinem Guden; Ayse Nihal Sari; Seyhan Sahan-Firat; Bahar Tunctan
Journal:  Neurochem Res       Date:  2021-01-02       Impact factor: 3.996

3.  Involvement of SRC-suppressed C kinase substrate in neuronal death caused by the lipopolysaccharide-induced reactive astrogliosis.

Authors:  Ping Wang; Linlin Sun; Aiguo Shen; Junling Yang; Xiaohong Li; Haiou Liu; Tao Tao; Chun Cheng; Xiang Lu
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

4.  Prior laparotomy or corticosterone potentiates lipopolysaccharide-induced fever and sickness behaviors.

Authors:  Leah E Hains; Lisa C Loram; Frederick R Taylor; Keith A Strand; Julie L Wieseler; Ruth M Barrientos; Jennifer J Young; Matthew G Frank; Julia Sobesky; Thomas J Martin; James C Eisenach; Steven F Maier; John D Johnson; Monika Fleshner; Linda R Watkins
Journal:  J Neuroimmunol       Date:  2011-09-09       Impact factor: 3.478

5.  Lipopolysaccharide from Porphyromonas gingivalis sensitizes capsaicin-sensitive nociceptors.

Authors:  Caio Cezar Randi Ferraz; Michael A Henry; Kenneth M Hargreaves; Anibal Diogenes
Journal:  J Endod       Date:  2011-01       Impact factor: 4.171

6.  The preventive effects of dexmedetomidine on endotoxin-induced exacerbated post-incisional pain in rats.

Authors:  Daiki Yamanaka; Takashi Kawano; Atsushi Nishigaki; Bun Aoyama; Hiroki Tateiwa; Marie Shigematsu-Locatelli; Fabricio M Locatelli; Masataka Yokoyama
Journal:  J Anesth       Date:  2017-05-24       Impact factor: 2.078

7.  Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.

Authors:  M R Hutchinson; K M Ramos; L C Loram; J Wieseler; P W Sholar; J J Kearney; M T Lewis; N Y Crysdale; Y Zhang; J A Harrison; S F Maier; K C Rice; L R Watkins
Journal:  Neuroscience       Date:  2009-09-27       Impact factor: 3.590

8.  The expression of tumor necrosis factor-alpha (TNF-alpha) by the intrathecal injection of lipopolysaccharide in the rat spinal cord.

Authors:  Aiguo Shen; Dan Zhou; Qin Shen; Hai-ou Liu; Linlin Sun; Yonghua Liu; Jianping Chen; Junling Yang; Yuhong Ji; Chun Cheng
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

9.  The roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammation.

Authors:  Dimitris N Xanthos; Naresh Kumar; Elvar Theodorsson; Terence J Coderre
Journal:  Neuropharmacology       Date:  2008-12-11       Impact factor: 5.250

10.  Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids.

Authors:  Katalin J Kovács; Jonathan C Papic; Alice A Larson
Journal:  Pain       Date:  2007-08-07       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.